2005;6(2):85-101. In summary, the aqueous suppressors timolol gel once daily and brinzolamide are recommended first-line glaucoma agents often used together, with timolol gel providing the ...

We know that the management of glaucoma becomes more expensive as the severity of the disease increases. In addition, we know from pivotal randomized clinical trials (including the Early Manifest ...

The ophthalmic solution is designed to treat high intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. According to IQVIA data, the product segment generated ...

PolyActiva aims for market availability of PA5108 by 2029, with phase 3 trials expected to take 2.5 years. PolyActiva has announced promising results from its phase 2 clinical trial of PA5108, a novel ...

Background: Propranolol, a nonselective β-blocker, is the first-line treatment for infantile hemangioma (IH). Topical timolol has recently been proposed as a novel IH treatment with fewer adverse ...